Pipeline
Product Candidate
Discovery
Preclinical
Clinical Phase I/II
Clinical Phase III
Bone augmentation in osteoporosis patients
Novel nano-materials for drug delivery
Vascularized bone grafts
Soft tissue grafts
Bonus BioGroup developed innovative technologies to realize the full potential of adipose-derived stromal cells with a unique capacity to treat a broad spectrum of diseases involving tissue damage, inflammation, and autoimmunity.
CELL THERAPY
Cell therapies are a living pharmacy, able to deploy multiple therapeutics instead of single drugs.
TISSUE ENGINEERING
It takes a village to grow a tissue, and one kind of cell is rarely enough.
info@bonus-bio.com
+972 (0)73 206 7104
Matam Advanced Technology
